Dupixent(generic name:dupilumab) is given as a subcutaneous (under the skin) injection into the thigh or stomach area by the patient or a caregiver. It can also be given in the outer area of the upper arm by a caregiver. It comes as a pre-filled syringe or a pre-filled autoinjector ...
Dupixent is administered as an injection under the skin (subcutaneous injection). It was first approved in March 2017. Bottom Line Atopic dermatitis (eczema): In adults and children, Dupixent (generic name: dupilumab) can start to work as quickly as 2 to 4 weeks to relieve itching due to ...
While topical treatments are sufficient for some patients, others may need next-level medications. These could include an injectable drug called dupilumab, which helps switch off some immune system signaling pathways that promote eczema. Topical immunomodulators (TIMS) are another class of drug that ...
Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis? J. Clin. Med. 2023, 12, 2189. [Google Scholar] [CrossRef] Pagan, A.D.; David, E.; Ungar, B.; Ghalili, S.; He, H.; Guttman-Yassky, E. Dupilumab Improves Clinical Scores in Children...